Media Release

Indian pharma companies to show healthy revenue growth of 7-9% in FY2026, even as US market risks loom

NHAI to garner Rs. 35,000–40,000 crore in FY2026 from road assets through toll-operate-transfer (TOT), Infrastructure Investment Trust (InvIT)

Average tariff hike of 4.5% along with reduction in AT&C losses below 15% needed to eliminate the gap between ACS and ARR

Residential area sales to dip by 0-3% in FY2026 to 620-640 msf for top seven cities in India

India’s exporters face rising US tariffs: Credit risks mount amid shifting trade dynamics

Credit growth of banks and non-banks to be supported by GST rate cuts

Apparel exports to shrink by 6-9% in FY2026; Outlook revised to Negative on tariff woes

Indian airline losses to widen to Rs. 95-105 billion in FY2026 amid geopolitical and trade headwinds

Credit metrics steady for India Inc., even as exports face pressure

GDP growth projected at 6.7% in Q1 FY2026, supported by upfronted Government spending, exports to some geographies